After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, ESPR falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $2.79 and fluctuated between $2.8750 as its day high and $2.6300 as its day low. The current market capitalization of Esperion Therapeutics Inc. is $475.47M. A total of 6.53 million shares were traded on the day, compared to an average of 6.42M shares.
In the most recent transaction, Warren Eric sold 742 shares of ESPR for 1.25 per share on Sep 20 ’23. After the transaction, the Chief Commercial Officer now owns 68,318 company shares. In a previous transaction on Aug 18 ’23, Warren Eric sold 243 shares at 1.41 per share. ESPR shares that Chief Commercial Officer owns now total 69,060.
Among the insiders who sold shares, Warren Eric disposed of 106 shares on Jul 19 ’23 at a per-share price of $1.58. This resulted in the Chief Commercial Officer holding 69,303 shares of ESPR after the transaction. In another insider transaction, Warren Eric sold 603 shares at $1.48 per share on Jun 21 ’23. Company shares held by the Chief Commercial Officer now total 69,409.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ESPR has a high of $3.34 and a low of $0.70.
As of this writing, ESPR has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $0.46 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.37 in the last quarter, which was 14.00% higher than expectations of -$0.43.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$3.85, while its Total Shareholder’s Equity was -$196.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.13.
